Nebius Diversifies Into Healthcare AI as Meta Looms as Rival

Nebius stock plunges 17% as Meta launches competing cloud service 'Meta Compute.' The AI infrastructure firm pivots to high-margin medical tech with $1.4M GPU grants for startups.

The arithmetic of the artificial intelligence infrastructure market is turning ugly for Nebius. The company that rode a $27 billion partnership with Meta Platforms to enormous gains now faces the prospect of that same ally becoming its most dangerous competitor. In response, management is forging a new path into regulated, high-margin medical technology.

On Thursday, Nebius expanded its “AI Discovery Awards” program, earmarking $1.4 million in computing capacity for start-ups working on medical devices and imaging. The awards provide access to the company’s GPU clusters for complex AI workloads. Alongside the grants, Nebius is preparing a dedicated healthcare platform designed to embed itself into the life-sciences sector, where regulatory barriers offer natural protection from commoditised cloud hosting.

The move comes just a day after the stock suffered its worst session in months. On Wednesday, shares plunged as much as 17% in US trading after reports emerged that Meta is building a cloud service called “Meta Compute.” The tech giant plans to sell its surplus artificial-intelligence compute to external developers, putting it in direct competition with the very infrastructure providers that have fed its own AI ambitions.

Nebius closed Wednesday at €201.35, and by the time the medical-awards announcement hit the wires the stock had slipped further to €199.60. That marks a decline of roughly 23% from the all-time high of €261.00 reached in late June. The annualised volatility of the stock now exceeds 100%, a stark reminder of the hair-trigger sentiment surrounding high-valuation AI names.

The irony is that Nebius’s underlying business has rarely looked stronger. In the first quarter of 2026, revenue surged 684% year-on-year to $399 million, while adjusted operating profit reached nearly $130 million. The order pipeline is at record levels, and the company is pressing ahead with construction of a new 310-megawatt facility in Finland.

But investors are fixated on the threat from Menlo Park. If Meta enters the market, it could flood cloud compute with cheap GPU capacity and squeeze margins across the industry. Meta also gains intimate knowledge of customer workflows and can bundle raw compute with its own models, locking developers into its ecosystem. A hard price war would test whether Nebius’s fat pipeline can absorb the margin pressure.

Insider behaviour has done little to steady nerves. Since the start of the year, company executives — including the chief technology officer and the head of infrastructure — have executed 17 sales of Nebius stock. Not a single insider purchase has been recorded.

Despite the recent slide, the shares are still up 161% year-to-date. The critical test will come with the next quarterly report, where the market will look for fresh customer contracts beyond the pure-tech sector. Progress on the Finnish data-centre build and any early signs that Meta Compute is landing its first external clients will also move the needle. For now, Nebius is betting that regulatory moats and specialised verticals can keep it one step ahead of the behemoth it once called a partner.